Sturge Simon's Form 4 filing
MoonLake Immunotherapeutics (MLTX) · filed Oct 8, 2024
- Accession no.
- 0001213900-24-086271
- Filed
- Oct 8, 2024
- Trade date
- Oct 4, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $9.19M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sturge SimonCIK 0001920785 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 4, 2024 | Class A ordinary shares, par value $0.0001 per share | SSaleDisposed | −171,000 | $53.72 | −$9,186,120 | 171,980 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.